Ethyl 5-(4-Bromophenyl)-4-methyl-1H-pyrrole-2-carboxylate

Por Marcus Baumann, Ian R. Baxendale
Publicado em 2017-08-01

8.5 HEMODYNAMICS DURING INTRA- AND INTERDIALYTIC PERIODS DEPEND ON ULTRAFILTRATION VOLUME

Por Christopher Mayer, Stephan Geilert, Julia Matschkal, Uwe Heemann, Marcus Baumann, Christoph Schmaderer
Publicado em 2016-11-01

P6.7 DETERMINANTS FOR DIFFERENCES IN CENTRAL SYSTOLIC BLOOD PRESSURE CAUSED BY DIFFERENT CALIBRATION METHODS

Por Christopher Mayer, Martin Bauhofer, Bernhard Hametner, Christoph Schmaderer, Uwe Heemann, Siegfried Wassertheurer*, Marcus Baumann
Publicado em 2015-11-01

11.5 DIFFERENCES OF HEART RATE VARIABILITY AND AUGMENTATION INDEX BETWEEN DIALYSIS AND POST-DIALYSIS PERIODS IN PATIENTS WITH END-STAGE RENAL DISEASE

Por Stefan Hagmair, Matthias Christoph Braunisch, Martin Bachler, Anna-Lena Hasenau, Axel Bauer, Konstantinos Rizas, Siegfried Wassertheurer, Marcus Baumann, Christopher Mayer, Christoph Schmaderer
Publicado em 2016-11-01

P107 OSCILLOMETRIC MEASUREMENT OF 24-HOUR PULSE WAVE VELOCITY PREDICTS ALL- CAUSE MORTALITY IN PATIENTS WITH END-STAGE RENAL DISEASE: THE ISAR-STUDY

Por Julia Matschkal, Christopher C. Mayer, Siegfried Wassertheurer, Georg Lorenz, Susanne Angermann, Stephan Kemmner, Matthias Braunisch, Roman Günthner, Bernhard Haller, Marcus Baumann, Uwe Heemann, Christoph Schmaderer
Publicado em 2017-12-01

2.4 CENTRAL SYSTOLIC BLOOD PRESSURE PROVIDES ADDITIONAL INFORMATION IN RISK PREDICTION IN HEMODIALYSIS PATIENTS

Por Christopher C. Mayer, Julia Matschkal, Pantelis A. Sarafidis, Stefan Hagmair, Georg Lorenz, Susanne Angermann, Matthias C. Braunisch, Marcus Baumann, Uwe Heemann, Christoph Schmaderer, Siegfried Wassertheurer
Publicado em 2018-12-01